Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease

Marie A. Roskrow; Cliona M. Rooney; Helen Heslop; Malcolm Brenner; Robert A. Krance; Mary V. Gresik; Kenneth McClain; Laura K. Aguilar; Bambi Grilley; Rob Elizabeth; George Carrum

doi:10.1089/hum.1998.9.8-1237

Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease

Marie A. Roskrow, Cliona M. Rooney, Helen Heslop, Malcolm Brenner, Robert A. Krance, Mary V. Gresik, Kenneth McClain, Laura K. Aguilar, Bambi Grilley, Rob Elizabeth, George Carrum

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Original language	English (US)
Pages (from-to)	1237-1250
Number of pages	14
Journal	Human Gene Therapy
Volume	9
Issue number	8
DOIs	https://doi.org/10.1089/hum.1998.9.8-1237
State	Published - May 20 1998

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Genetics

Access to Document

10.1089/hum.1998.9.8-1237

Cite this

Roskrow, M. A., Rooney, C. M., Heslop, H., Brenner, M., Krance, R. A., Gresik, M. V., McClain, K., Aguilar, L. K., Grilley, B., Elizabeth, R., & Carrum, G. (1998). Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease. Human Gene Therapy, 9(8), 1237-1250. https://doi.org/10.1089/hum.1998.9.8-1237

Roskrow, MA, Rooney, CM, Heslop, H , Brenner, M, Krance, RA, Gresik, MV, McClain, K, Aguilar, LK, Grilley, B, Elizabeth, R & Carrum, G 1998, 'Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease', Human Gene Therapy, vol. 9, no. 8, pp. 1237-1250. https://doi.org/10.1089/hum.1998.9.8-1237

@article{4ccdafdbe2ab4b1e9efcbeecf3fce874,

title = "Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease",

author = "Roskrow, {Marie A.} and Rooney, {Cliona M.} and Helen Heslop and Malcolm Brenner and Krance, {Robert A.} and Gresik, {Mary V.} and Kenneth McClain and Aguilar, {Laura K.} and Bambi Grilley and Rob Elizabeth and George Carrum",

year = "1998",

month = may,

day = "20",

doi = "10.1089/hum.1998.9.8-1237",

language = "English (US)",

volume = "9",

pages = "1237--1250",

journal = "Human Gene Therapy",

issn = "1043-0342",

publisher = "Mary Ann Liebert Inc.",

number = "8",

}

TY - JOUR

T1 - Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease

AU - Roskrow, Marie A.

AU - Rooney, Cliona M.

AU - Heslop, Helen

AU - Brenner, Malcolm

AU - Krance, Robert A.

AU - Gresik, Mary V.

AU - McClain, Kenneth

AU - Aguilar, Laura K.

AU - Grilley, Bambi

AU - Elizabeth, Rob

AU - Carrum, George

PY - 1998/5/20

Y1 - 1998/5/20

UR - http://www.scopus.com/inward/record.url?scp=17344363490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17344363490&partnerID=8YFLogxK

U2 - 10.1089/hum.1998.9.8-1237

DO - 10.1089/hum.1998.9.8-1237

M3 - Article

C2 - 9625264

AN - SCOPUS:17344363490

SN - 1043-0342

VL - 9

SP - 1237

EP - 1250

JO - Human Gene Therapy

JF - Human Gene Therapy

IS - 8

ER -

Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this